Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 19, Number 6—June 2013


Human Papillomavirus Genital Infections among Men, China, 2007–2009

Zhonghu He1, Ying Liu1, Yuan Sun1, Long Fu Xi, Ke Chen, Yiqiang Zhao, Lei Gao, Fangfang Liu, Yaqi Pan, Tao Ning, Lixin Zhang, Hong Cai, and Yang KeComments to Author 
Author affiliations: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Laboratory of Genetics, Peking University Cancer Hospital and Institute, Beijing, People’s Republic of China (Z. He, Y. Liu, Y. Sun, K. Chen, Y. Zhao, L. Gao, F. Liu, Y. Pan, T. Ning, H. Cai, Y. Ke); University of Washington, Seattle, Washington, USA (L.F. Xi); Anyang Cancer Hospital, Anyang, People’s Republic of China (L. Zhang)

Cite This Article


Highlight and copy the desired format.

EID He Z, Liu Y, Sun Y, Xi L, Chen K, Zhao Y, et al. Human Papillomavirus Genital Infections among Men, China, 2007–2009. Emerg Infect Dis. 2013;19(6):992-995.
AMA He Z, Liu Y, Sun Y, et al. Human Papillomavirus Genital Infections among Men, China, 2007–2009. Emerging Infectious Diseases. 2013;19(6):992-995. doi:10.3201/eid1906.111597.
APA He, Z., Liu, Y., Sun, Y., Xi, L., Chen, K., Zhao, Y....Ke, Y. (2013). Human Papillomavirus Genital Infections among Men, China, 2007–2009. Emerging Infectious Diseases, 19(6), 992-995.


To determine prevalence of genital human papillomavirus (HPV) infection among men in rural China, we analyzed genital swab specimens. Among 2,236 male residents of rural Henan Province, HPV infection prevalence was 17.5%. The most common oncogenic and nononcogenic types were HPV-16 and HPV-3, respectively. Infection was associated with younger age and multiple sex partners.

Human papillomavirus (HPV) is an etiologic agent of cervical cancer. Among men, genital HPV infection plays a role in the development of anogenital cancer (1). Estimates of HPV infection prevalence among heterosexual men, mostly from North America and Europe, vary substantially (3.5%–45%) (1,2). In the People’s Republic of China, estimated HPV prevalence among women varies by geographic location (3), but no such estimate is available for men. Therefore, we conducted this cross-sectional study to determine the prevalence of genital HPV infection in a large population of men in a rural province of China and to evaluate relevant factors.

The Study

In 2007–2009, a population-based esophageal cancer cohort study was initiated in 9 villages in rural Anyang, Henan Province, China (4). This HPV investigation was added to the original cohort study in 6 of the 9 villages. Eligibility criteria were as follows: 1) male sex; 2) permanent residency in the target villages; 3) age 25–65 years; and 4) no history of cancer, cardiovascular disease, or mental disorder. Of 3,571 eligible men, 3,172 (89%) were enrolled. The main reason why the other 399, who were substantially younger, did not participate was loss of contact because they were employed outside Anyang.

Participants were interviewed, and exfoliated cells were collected from the penile shaft, glans penis, coronal sulcus, and scrotum by using saline-soaked swabs (5). The sampling procedure was identical for circumcised and uncircumcised men. To assess the adequacy of the specimens, we tested each specimen by PCR for the β-globin gene. Positive specimens were subsequently tested for 13 oncogenic and 37 nononcogenic types of HPV by using PCR-based direct sequencing with a pair of SPF1/GP6+ primers (6). Samples with ambiguous HPV typing signals were subjected to further cloning and sequencing.

To evaluate the associations between exposure variables and the presence of HPV DNA, we used logistic regression analysis with stepwise backward elimination at p>0.1. To examine the association across the ordered categorical variables, we used a trend test.

Of 3,172 specimens tested, 2,236 were positive for β-globin and were included in the analysis (median participant age 42 years; interquartile range 35–52 years). We excluded from the study men who were older and reported less risky sexual behavior than those who were included (Technical Appendix [PDF - 58 KB - 1 page]).

Of the 40 HPV types we tested for, we detected 36, including 13 oncogenic types. Overall prevalence of HPV infection was 17.5% (95% CI 16%–19%). Oncogenic HPV was detected in 140 (6.3%; 95% CI 5.3%–7.3%) specimens, and nononcogenic HPV was detected in 251 (11%; 95% CI 9.9%–13%) specimens. Among 15 HPV-positive specimens that had ambiguous direct sequencing signals and were further cloned and resequenced for genotyping, 3 had a second type and minor types were ignored. Among these infections (Table 1), the most common oncogenic type detected was HPV-16 (17.4%), followed by HPV-18 (7.2%). The most common nononcogenic type was HPV-3 (16.4%), followed by HPV-57 (7.9%).

Prevalence of infection of any or nononcogenic HPV types decreased significantly with participant’s increasing age (Table 2). Risk for infection with any HPV type was associated with being unmarried, having had multiple sex partners, and having had oral and anal sex. When the outcome was stratified by oncogenicity of HPV type, the association remained statistically significant for having had multiple sex partners.


This study of genital HPV in a large sample of adult men from rural China addresses the paucity of data on male genital HPV infection in Asia. Prevalence rates for any type of HPV and oncogenic HPV were lower among these men in China than among heterosexual men elsewhere (Asia–Pacific area and globally) (2,7). This discrepancy might be partly explained by the relatively more conservative sexual behavior and higher median age of participants in this study.

Among populations of similar age, prevalence of a specific HPV type is usually lower among men than among women (1). However, the 17.5% prevalence found in this study exceeds estimates for married women 15–59 years of age in China (14.8%–16.8%) (8). This finding is consistent with that of another study, which also reported higher HPV prevalence among men than among women (9). These inconsistent findings might be explained by differences in HPV type distribution between male genitalia and the female cervix and by variability of type-specific sensitivity in detection methods.

Although most studies of HPV infection in men worldwide have found no clear trend with regard to age (1), we found that infection mildly decreased with increasing age. A potential explanation for this age-related trend might be that in this population, young adults more commonly work for long periods outside the rural home area than do older adults (data not shown), and the increased mobility might be associated with more unprotected sexual behavior and consequent increased exposure to HPV (10).

Our finding that HPV-16 and -18 were the most commonly detected oncogenic HPV types is in keeping with findings of previous studies (2,7,11,12). However, our finding that HPV-3 and HPV-57 were the predominant nononcogenic types is in contrast to the findings of other studies that HPV-6 and HPV-11 were the most predominant (2,11,13). This discrepancy might partly be explained by the fact that in our in-house evaluation, the primer set SPF1/GP6+ was more sensitive for HPV-57 but less sensitive for HPV-11 than was GP5+/GP6+. Completely opposite to our findings, Dai et al. reported that among women in neighboring rural Shanxi Province, China, oncogenic types were more commonly detected than were nononcogenic types (14). One possible explanation is that in our study, a significant portion of the exfoliated cells were collected from skin tissue. Therefore, a number of cutaneous HPV types, which are nononcogenic for mucosal lesion (cervical cancer), could be detected. We believe this might have led to the higher proportion of nononcogenic HPV than oncogenic HPV detected in our study. Another possible explanation is that sequencing methods used in our study can detect more nononcogenic types, which escape identification in studies that use hybridization with preassigned probes.

In contrast to previously reported rates of infection (7,12), in our study, infection with multiple types was rare. The previous studies used hybridization, an efficient way to identify co-infections, for genotyping. However, we used sequencing instead of hybridization to maximize demonstration of the spectrum of HPV types. Because minor types would probably be covered by the predominant type in the sequencing process, sequencing would probably have resulted in underestimation of infection with multiple types.

The low proportion of β-globin positivity might have partly resulted from the lower efficiency of cell collection by use of a saline-moistened swab as opposed to other methods such as emery paper (15). Another possible explanation is that a certain proportion of cells collected from male genitalia are keratinized and contain less nucleated human DNA than cells collected from mucosal organs (e.g., the cervix) (15).

The age range of the male participants in this large study was broad. However, the biases potentially imposed by the nonparticipation of ≈400 younger men (because of mobility) and 936 older men (because of specimen inadequacy) must be noted. This nonparticipation of younger men might have neutralized the age-related association to some extent. Although circumcision is extremely rare in rural China, the lack of accurate data for this variable is another study limitation, which rendered subgroup analysis by circumcision status impossible.

As reported in other studies (1), having had multiple sex partners was associated with HPV infection in this population. This finding indicates that men with higher mobility (i.e., higher risk for multiple sex partners and unprotected sexual behavior) should receive more attention with regard to future HPV control in this region.

Dr He is a researcher at the Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Laboratory of Genetics, Peking University Cancer Hospital and Institute. His primary research interests are cancer epidemiology and biostatistics.


We thank Michael A. McNutt and Rachel V. Pearline for editing and correcting this manuscript.

This work was supported by Natural Science Foundation of China grant no. 30872937, 30930102, “973” Project of National Ministry of Science and Technology grant no. 2011CB504300, 2012CB910800, “863” Key Projects of National Ministry of Science and Technology grant no. 2006AA2Z467, Charity Project of National Ministry of Health grant no. 2011CB504300, 200902002, and Natural Science Foundation of Beijing grant no. 7100001, all to Y.K.


  1. Partridge JM, Koutsky LA. Genital human papillomavirus infection in men. Lancet Infect Dis. 2006;6:2131. DOIPubMed
  2. Vardas E, Giuliano AR, Goldstone S, Palefsky JM, Moreira ED Jr, Penny ME, External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continents. J Infect Dis. 2011;203:5865. DOIPubMed
  3. Shi JF, Canfell K, Lew JB, Qiao YL. The burden of cervical cancer in China: synthesis of the evidence. Int J Cancer. 2012;130:64152. DOIPubMed
  4. Liu F, Guo F, Zhou Y, He Z, Tian X, Guo C, The Anyang Esophageal Cancer Cohort Study: study design, implementation of fieldwork, and use of computer-aided survey system. PLoS ONE. 2012;7:e31602. DOIPubMed
  5. Giuliano AR, Nielson CM, Flores R, Dunne EF, Abrahamsen M, Papenfuss MR, The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV Detection in Men study. J Infect Dis. 2007;196:114652. DOIPubMed
  6. Huang SL, Chao A, Hsueh S, Chao FY, Huang CC, Yang JE, Comparison between the Hybrid Capture II Test and an SPF1/GP6+ PCR–based assay for detection of human papillomavirus DNA in cervical swab samples. J Clin Microbiol. 2006;44:17339. DOIPubMed
  7. Nielson CM, Harris RB, Flores R, Abrahamsen M, Papenfuss MR, Dunne EF, Multiple-type human papillomavirus infection in male anogenital sites: prevalence and associated factors. Cancer Epidemiol Biomarkers Prev. 2009;18:107783. DOIPubMed
  8. Shi JF, Qiao YL, Smith JS, Dondog B, Bao YP, Dai M, Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia. Vaccine. 2008;26(Suppl 12):M539. DOIPubMed
  9. Van Doornum GJ, Prins M, Juffermans LH, Hooykaas C, van den Hoek JA, Coutinho RA, Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study. Genitourin Med. 1994;70:2406 .PubMed
  10. Sudhinaraset M, Astone N, Blum RW. Migration and unprotected sex in Shanghai, China: correlates of condom use and contraceptive consistency across migrant and nonmigrant youth. J Adolesc Health. 2012;50:S6874. DOIPubMed
  11. Goldstone S, Palefsky JM, Giuliano AR, Moreira ED Jr, Aranda C, Jessen H, Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men. J Infect Dis. 2011;203:6674. DOIPubMed
  12. Smith JS, Backes DM, Hudgens MG, Bailey RC, Veronesi G, Bogaarts M, Prevalence and risk factors of human papillomavirus infection by penile site in uncircumcised Kenyan men. Int J Cancer. 2010;126:5727. DOIPubMed
  13. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology. 2004;324:1727. DOIPubMed
  14. Dai M, Bao YP, Li N, Clifford GM, Vaccarella S, Snijders PJ, Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer. 2006;95:96101. DOIPubMed
  15. Weaver BA, Feng Q, Holmes KK, Kiviat N, Lee SK, Meyer C, Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. J Infect Dis. 2004;189:67785. DOIPubMed


Technical Appendix

Cite This Article

DOI: 10.3201/eid1906.111597

1These authors contributed equally to this article.

Table of Contents – Volume 19, Number 6—June 2013


Please use the form below to submit correspondence to the authors or contact them at the following address:

Yang Ke, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Laboratory of Genetics, Peking University Cancer Hospital and Institute, No. 52 Fucheng Rd, Haidian District, Beijing 100042, People’s Republic of China

character(s) remaining.

Comment submitted successfully, thank you for your feedback.